{"name":"Consorci Sanitari Integral","slug":"consorci-sanitari-integral","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"basal bolus insulin therapy","genericName":"basal bolus insulin therapy","slug":"basal-bolus-insulin-therapy","indication":"Type 1 diabetes mellitus","status":"marketed"}]}],"pipeline":[{"name":"basal bolus insulin therapy","genericName":"basal bolus insulin therapy","slug":"basal-bolus-insulin-therapy","phase":"marketed","mechanism":"Basal bolus insulin therapy replaces the body's natural insulin secretion by providing a long-acting basal insulin dose once or twice daily plus rapid-acting bolus insulin doses with meals to control blood glucose.","indications":["Type 1 diabetes mellitus","Type 2 diabetes mellitus (when other agents insufficient)"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}